Skip to main content

Peer Review reports

From: Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer types

Original Submission
19 Oct 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Nov 2022 Reviewed Reviewer Report
30 Nov 2022 Reviewed Reviewer Report
31 Dec 2022 Author responded Author comments - Xinjun Wang
Resubmission - Version 3
31 Dec 2022 Submitted Manuscript version 3
3 Jan 2023 Author responded Author comments - Xinjun Wang
Resubmission - Version 4
3 Jan 2023 Submitted Manuscript version 4
4 Jan 2023 Author responded Author comments - Xinjun Wang
Resubmission - Version 5
4 Jan 2023 Submitted Manuscript version 5
4 Jan 2023 Author responded Author comments - Xinjun Wang
Resubmission - Version 6
4 Jan 2023 Submitted Manuscript version 6
15 Jan 2023 Reviewed Reviewer Report
15 Jan 2023 Reviewed Reviewer Report
17 Jan 2023 Author responded Author comments - Xinjun Wang
Resubmission - Version 7
17 Jan 2023 Submitted Manuscript version 7
17 Jan 2023 Author responded Author comments - Xinjun Wang
Resubmission - Version 8
17 Jan 2023 Submitted Manuscript version 8
18 Jan 2023 Author responded Author comments - Xinjun Wang
Resubmission - Version 9
18 Jan 2023 Submitted Manuscript version 9
Publishing
23 Jan 2023 Editorially accepted
30 Jan 2023 Article published 10.1186/s12885-023-10575-1

You can find further information about peer review here.

Back to article page